| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -1.5% | -1.5% | -1.5% |
| 20D | 1Small sample | 100.0% (1/1) | 100.0% (1/1) | +1.5% | +1.5% | +1.5% |
| 60D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -11.2% | -11.2% | -11.2% |
| 120D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -14.9% | -14.9% | -14.9% |
COMPANY RESEARCH
Kooth plc
KOO.L · United Kingdom · Healthcare · Health Information Services
INSIDER SIGNAL
Insider activity score：68.9 / 100
2 insiders · 2 purchase events · €2.09m net purchases
Europe #84 · United Kingdom #26
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
Cluster+21.0 / 35
How many distinct insiders bought in the cluster
Purchase size+23.6 / 25
Purchase value relative to company size and liquidity
Role+13.0 / 20
The seniority and relevance of participating insiders
Recency+10.0 / 10
How recently the purchases occurred
Conviction+7.3 / 10
How clearly buying stands out from other activity
What is holding the score back?
- ⚠ Buyer breadth is moderate · fewer than 4 distinct filers
- ⚠ Insider role contributes less on the current role scale
- ✓ Recent activity · latest purchase 2026-10-23
The role contribution uses the inverted role input of the current European model.
Buying concentration
78%
Largest buyer：ScaleUp 2026 LP · 3.60m GBP
Gross qualified purchase transaction-line value：4.63m GBP
The headline € total is net buying for the screen; this module uses gross qualified purchase transaction-line values in the filing currency, so the amounts can differ. The current 15-day buyer-breadth input counts distinct buyers; value concentration is disclosed separately here.
This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.
Key purchase quotes (filing currency)
| Filer | Price per unit | Trade date |
|---|---|---|
| ScaleUp 2026 LP | 1.35 GBP | Oct 23, 2026 |
| ScaleUp Capital Limited | 1.35 GBP | Oct 23, 2026 |
Model details
Cluster breakdown (does not change the score)
- 15-day buyer breadth (count)
- 2 distinct reported filers
- Peak time window
- 2026-10-23 to 2026-10-23
- Current breadth input
- 0.600 (capped at 4+ buyers)
- Buyer independence
- Not yet measured; related-party fields are not cross-market comparable
What the filings show
- 🟢 Recent eligible purchase
ScaleUp 2026 LP · 3.60m GBP · Price 1.35 GBP · Oct 23, 2026 - 🟢 PDMR purchase
ScaleUp Capital Limited · 1.03m GBP · Price 1.35 GBP · Oct 23, 2026 - 🔴 1 other transaction line(s) are not counted as discretionary-buying evidence; 0 have zero price
Insider vs stock price
1 purchase day(s), 2 purchase line(s) in the 180-day window. 1 sale day(s), 1 sale line(s).
Daily close (GBp)Day with an insider purchaseTwo or more insiders the same dayDay with an insider sale
Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.
Insider timeline
2 insiders bought on the same day, 23 Oct: 2 Associated person. The share closed at 182.50 that day and at 182.50 most recently (+0.0%). That week 106 companies across Europe disclosed insider purchases, an ordinary week (26 of the last 26).
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
×A sale
A cross is one insider's sales on one day. People sell to pay tax, to cash in share awards or to hold less of one company, so a sale says less than a purchase does. When someone bought and sold on the same day, the cross sits beside the dot. The totals are under “Purchases against sales” below.
▮Purple band: several insiders bought within 15 days
The band marks the stretch with the most different buyers: at most 15 days long and at least two people. Here it is 23 Oct, with 2 insiders. Only the strongest stretch is marked. Several people deciding the same thing is harder to explain by one person's private reasons, but insiders often buy together just after a closed period ends, so compare it with the grey weekly bars.
Blue line: this share's price, +37.7% over these six months
The closing price of each day, from 132.50 on 2026-04-27 to 182.50 on 2026-10-23. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, +4.2%
Taken from the 610 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share +37.7%, the typical one +4.2%, 33.5 points ahead. It is not an index and not a comparison within one industry.
▂Grey bars: companies across Europe disclosing purchases each week
A taller bar is a week in which more companies disclosed insider purchases. The purple bar is the week of the band above: 106 companies, number 26 of the last 26 weeks. If that week was a peak anyway, buying together is less special than it looks.
This company: insiders buying per month, last 12 months
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
2Oct
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since | Earlier purchases |
|---|---|---|---|---|---|---|---|
| Root Capital Fund II LP | Associated person | — | 1 | — | — | — | fewer than 5 completed |
| ScaleUp 2026 LP | Associated person | 1 | — | 3.6M GBP | 2026-10-23 | +0.0% | fewer than 5 completed |
| ScaleUp Capital Limited | Associated person | 1 | — | 1.0M GBP | 2026-10-23 | +0.0% | fewer than 5 completed |
Purchases against sales
Purchases82%4.6M GBP · 2 line(s) · 2 insider(s)
Sales18%1.0M GBP · 1 line(s) · 1 insider(s)
Shares of the reported value of insider transactions in the 180-day window. Sales include disposals for tax, at option exercise or under a pre-set plan, which say little about an insider's view. The split describes what was disclosed; it is not a signal.
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 0.600 | 21.0 |
| Qualified-buy size | 25% | 0.943 | 23.6 |
| Role informativeness (inverted) | 20% | 0.350 | 7.0 |
| Recency | 10% | 1.000 | 10.0 |
| Buy/sell conviction | 10% | 0.730 | 7.3 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
All bull and bear lists, and what followed each line in the past →
Where the evidence comes from
Independent evidence does not object: the purchases themselves carry bull lines (more buyers than usual here, large purchases, bought in the last two weeks); share price and trading, short sellers, company results, company actions were checked and none crosses a bear threshold.
- The insider purchases themselvesBullmore buyers than usual here, large purchases, bought in the last two weeks Bearinsiders also sold3 checked, under the threshold · 3 missing
- Share price and tradingBearthinly traded2 checked, under the threshold
- Short sellers1 checked, under the threshold
- Company results1 checked, under the threshold · 1 missing
- Company actions1 checked, under the threshold
Bull case · the buying is informative
- No insider bought in the 180 days before this window; 2 have bought in it. The buying is new for this company, not a habit.Record: after 3,162 earlier disclosures like this, the median 60-session excess return was −2.7%, within 1 percentage point of all comparable disclosures (−2.7%).
- Net purchases of €2.1M equal 2.6% of the company's market value (€79.7M): large for the size of the business.
- The latest purchase is 0 days old (2026-10-23). The buying is current, not left over from an earlier quarter.
Bear case · discount it
- Insiders also sold €1.2M in the same 180 days, 37% of the amount bought.
- Share price and tradingAbout €308k of the stock changes hands on an average day, below this site's €500k screening line. A position is hard to enter or leave at the quoted price.
Evidence still missing
- No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
- Only one reading of profitability is held (profit margin 9.4%). Whether earnings and cash flow are rising or falling needs the last two reports side by side.
- European notifications have no field saying whether a purchase was pre-arranged; there is no counterpart to the US 10b5-1 box. None of the 2 purchase lines mentions a plan, but a bare “Acquisition of ordinary shares by way of off-market transfer” does not rule one out.
- The filings give the size of each trade, not what the buyer already held. Whether a purchase added 1% to a personal stake or doubled it is not known.
Checked and under the threshold: 8, 2 close to it
- BullAt most 2 insiders bought within any 15 days. Counted for the bull side from 3. close to the threshold
- BearThe largest buyer accounts for 78% of the value bought. Counted for the bear side from 80%. close to the threshold
- Bear0 of 2 buyers filed as a person closely associated with a manager. Counted for the bear side from half.
- BearThe share price changed +38% over six months (three months +17%, one month +8.3%) and stands 10% below its 52-week high. Counted for the bear side from a fall of 20%.
- BearOver three months the share price changed +17% and the median of 302 Healthcare companies changed −5.8%: ahead by 22 points. Counted for the bear side from 20 points behind.
- BearThe register of FCA shows no published net short position in this company.
- BullThe company announced no transaction in its own shares in the last 30 days.
- BearProfit margin on the latest captured figures is 9.4%. Counted for the bear side when negative.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
68.9 / 100
Latest recorded score
→ +0.0 ptssince the first recorded snapshot on 2026-10-23; 0 calendar days observed
- Recorded snapshots
- 1
- First snapshot
- 2026-10-23
There is not yet a 30-calendar-day comparison; earlier scores are not reconstructed. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Less than 30 days of comparable history is available, so factor movement is not yet decomposed.
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 68.9
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-10-23 | 68.9 |
Sector context
- Buying breadth
- 5.8% (46 / 791 issuers)
- Sector rank
- #12 / 12
- 7D breadth change
- -1.0 pp · vs 2026-10-16 (7d)
- 30D breadth change
- History building
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
Historical performance following insider filings. The company role is translated below each name while preserving the original title.
- Excess return = stock return − FTSE 100 return over the same period.
- Hit rate = completed events with positive excess return ÷ total completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
- Small-sample rule: n<5 is shown for transparency and is not scored.
Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -1.5% | -1.5% | -1.5% |
| 20D | 1Small sample | 100.0% (1/1) | 100.0% (1/1) | +1.5% | +1.5% | +1.5% |
| 60D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -11.2% | -11.2% | -11.2% |
| 120D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -14.9% | -14.9% | -14.9% |
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- 46.7%
- Beta
- 1.32
- Avg daily volume
- £223,031.4
VALUATION
- Market cap
- £66.8M
- P/E
- 12.2×
FUNDAMENTALS
- Profit margin
- 9.4%
- ROE
- 18.9%
- Industry
- Health Information Services
Prices to 23 Oct 2026: OpenBB/yfinance. From OpenBB/yfinance, captured 23 Oct 2026: Market cap, P/E, Profit margin, ROE, Beta, Industry. It does not affect the insider score or rank.
Disclosed net short positions
The FCA register, read 23 Oct 2026, publishes no aggregate net short position for this issuer.
Short-position disclosures are external context; they do not affect the insider score, ranking, or filing eligibility.
Insiders and institutions
Insiders, ranking window: €2.1M net bought · buyers: 2 · last 2026-10-23
Short sellers
Nothing at or above the publication threshold is on the FCA register (read 2026-10-23).
Source: FCA, read 2026-10-23. Where holders are named, only positions of 0.5% of issued capital or more are published, so these are lower bounds and a change is a change in what was published. Context only; not part of the score. All companies where insiders buy and short sellers hold positions →
Major holders (3% and above)
| Holder | Voting rights | Notified | Change |
|---|---|---|---|
| Root Capital Fund II LP | 25.20% | 2024-10-08 | −10.30 pp |
| River Global Investors LLP | 9.85% | 2025-06-02 | −0.28 pp |
| Harwood Capital LLP | 9.02% | 2025-09-24 | +0.64 pp |
| Perpetual Limited | 7.70% | 2024-10-25 | +1.65 pp |
| BGF Investment Management Limited | 6.15% | 2023-11-10 | +0.72 pp |
| Gresham House Asset Management Ltd | 4.49% | 2025-10-08 | −4.22 pp |
| CANACCORD GENUITY GROUP INC | 3.38% | 2024-11-25 | −5.58 pp |
No holder other than banks and brokers notified a change in the last 12 months.
Source: FCA (TR-1). A holder must notify when its voting rights cross 3% and every whole percent above it; within a percent a holding can change without a notice. Banks and brokers often hold shares to hedge clients' trades; the largest asset managers' stakes are mostly index money. Context only; not part of the score.
Insiders' buying price vs the latest close
Insiders paid 1.35 GBP a share on average (2 purchase lines, 2 buyers, 2026-10-23 – 2026-10-23). The close on 2026-10-23 was 35.2% above that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Buying size vs market trading
89.73% · of estimated traded value in the same period
2026-09-28 – 2026-10-23 · 20 recorded trading sessions
- Disclosed qualifying purchases
- 4,629,967 GBP
- Estimated market traded value
- 5,159,811 GBP
Market-data coverage: 507 verified sessions · Latest session: 2026-10-23 · Ratio status: Available
Recent and largest purchase events / preceding 60-session ADTV
- Oct 23 · ScaleUp 2026 LP · PCA of Simon Philips, Non-Executive Director of Kooth plc3,600,000 GBP · 1413.76%254,640 GBP ADTV
- Oct 23 · ScaleUp Capital Limited · PCA of Simon Philips, Non-Executive Director of Kooth plc1,029,966 GBP · 404.48%254,640 GBP ADTV
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Latest news
News capture status: ok. Articles were retained for audit but none met the reader threshold.
Regulatory filings
- Insider filing announcement · published 2026-10-23 · trade date 2026-10-23
- Insider filing announcement · published 2026-02-11 · trade date 2026-02-11
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
2 qualifying purchase disclosure(s) · 2 transaction line(s)
Oct 23, 2026Acquisition of ordinary shares by way of off-market transfer
ScaleUp 2026 LP · PCA of Simon Philips, Non-Executive Director of Kooth plc
Ordinary shares of £0.05 each ISIN: GB00BMCZLK30 · 2666667 shares × 1.35 GBP · —
Open filingOct 23, 2026Acquisition of ordinary shares by way of off-market transfer
ScaleUp Capital Limited · PCA of Simon Philips, Non-Executive Director of Kooth plc
Ordinary shares of £0.05 each ISIN: GB00BMCZLK30 · 762938 shares × 1.35 GBP · —
Open filingShowing 2 of 2 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
View 3 other transaction(s)
Oct 23, 2026Disposal of ordinary shares by way of off-market transfer
Root Capital Fund II LP · PCA of Simon Philips, Non-Executive Director of Kooth plc
Ordinary shares of £0.05 each ISIN: GB00BMCZLK30 · 762938 shares × 1.35 GBP · —
Open filingFeb 11, 2026Grant of options over ordinary shares under the Company's LTIP
Kate Newhouse · Chief Executive Officer
Ordinary shares of £0.05 each ISIN: GB00BMCZLK30 · — shares × — · —
Open filingFeb 11, 2026Grant of options over ordinary shares under the Company's LTIP
Sanjay Jawa · Chief Financial Officer
Ordinary shares of £0.05 each ISIN: GB00BMCZLK30 · — shares × — · —
Open filingShowing 3 of 3 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Follow new disclosures
Subscribe to new Europe disclosures. These are market-wide RSS feeds, not company-specific alerts.
Snapshot & identity
- Snapshot date
- 2026-10-23
- Ticker
- KOO.L
- ISIN
- GB00BMCZLK30
- Sector
- Healthcare
- Industry
- Health Information Services
Company logos by Parqet